High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission - 22/10/21
, Kathleen Riederer, MT (ASCP), Mamta Sharma, MD, FACP, FIDSA, Elisa Akagi Fukushima, MD, Leonard Johnson, MD, FACP, FIDSA, Louis Saravolatz, MD, MACP, FIDSAHighlights |
• | High rates of bacteremia noted among COVID-19 patients on hospital admission. |
• | Higher rates of MDROs on hospital admission compared to nosocomial acquisition. |
• | Bacteremia with MDROs should be considered among at risk population. |
Résumé |
We investigated the clinical implications of bacteremia among hospitalized COVID-19 patients. Higher rates (52.1%) of multidrug resistant organisms (MDRO) were noted on hospital admission compared to nosocomial acquisition (25%). Methicillin resistant Staphylococcus aureus was the predominant pathogen. Bacteremia with MDRO should be considered in the differential diagnosis among at risk populations especially those admitted from nursing facilities.
Le texte complet de cet article est disponible en PDF.Key Words : SARS-CoV-2, Bacteremia, Antimicrobial resistance, Bloodstream infections
Plan
| Funding/support: There was no funding involved in our study. |
|
| All the authors have no association that might pose a conflict of interest. |
|
| Conflict of interest: Ashish Bhargava, MD, FACP, No Conflicts of Interest |
|
| Kathleen Riederer, No Conflicts of Interest |
|
| Mamta Sharma, No Conflicts of Interest |
|
| Elisa Akagi Fukushima, MD, No Conflicts of Interest |
|
| Leonard Johnson, MD, FACP, FIDSA, No Conflicts of Interest |
|
| Louis Saravolatz, MD, MACP, FIDSA, No Conflicts of Interest |
Vol 49 - N° 11
P. 1441-1442 - novembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
